Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT03952494
Eligibility Criteria:
Inclusion Criteria:
Patients who quality the criteria below:
* Patients with nonpsychotic MDD
* Patients who would like to either start a new antidepressant or change their existing antidepressant treatment
* Patients for whom antidepressant treatment is deemed appropriate by the treating clinician
* \>18 years of age
* Willingness to provide signed informed consent to participate in the study
* Will be following up or continuously visiting their physician
Providers:
* Outpatient practice providers
* Providers who are familiar with Epic
Exclusion Criteria:
Patients:
* Patients with medical contraindications that preclude antidepressant treatment
* Patients with schizophrenia, schizoaffective disorder, or who have Bipolar I disorder
* Patients currently on antipsychotic medications (e.g., typical and atypical antipsychotic drugs) and mood stabilizing agents (e.g., lithium, carbamazepine, valproate, lamotrigine, gabapentin, or other anticonvulsants)
* Patients who are pregnant or have severe cognitive impairment
* Patients requiring urgent care or inpatient hospitalization at the time of consent
Providers:
• Unable or unwilling to commit time to introduce myGenes study to patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT03952494
Study Brief:
Protocol Section:
NCT03952494